VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells

DNA and Cell Biology

Volumn 19, Issue 5, 2000, Pages 253-263

  Zhang, Hongtao ^a   Wang, Qiang ^a   Kajino, Kiichi ^a   Greene, Mark I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMINO ACID; BRCA1 PROTEIN; CYTOPLASM PROTEIN; EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ARTICLE; BREAST CARCINOMA; CELL ACTIVITY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BINDING SITES; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BRCA1 PROTEIN; CELL CYCLE PROTEINS; CELL NUCLEUS; EPIDERMAL GROWTH FACTOR; HUMANS; MOLECULAR WEIGHT; PHOSPHORYLATION; PRECIPITIN TESTS; SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0033855808     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/10445490050021168     Document Type: Article

References (46)

1. BAUMANN, P., BENSON, F.E., and WEST, S.C. (1996). Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87, 757-766.
2. BEYER, A. (1997). Sequence analysis of the AAA protein family. Protein Sci. 6, 2043-2058.
3. CHAPMAN, M.S., and VERMA, I.M. (1996). Transcriptional activation by BRCA1 [letter; comment]. Nature 382, 678-679.
4. CHEN, C.F., LI, S., CHEN, Y., CHEN, P.L., SHARP, Z.D., and LEE, W.H. (1996a). The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J. Biol. Chem. 271, 32863-32868.
5. CHEN, Y., FARMER, A.A., CHEN, C.F., JONES, D.C., CHEN, P.L., and LEE, W.H. (1996b). BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56, 3168-3172.
6. COUCH, F.J., DESHANO, M.L., BLACKWOOD, M.A., CALZONE, K., STOPFER, J., CAMPEAU, L., GANGULY, A., REBBECK, T., and WEBER, B.L. (1997). BRCAI mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336, 1409-1415.
7. alpha. J. Biol. Chem. 273, 3562-3573.
8. DREBIN, J.A., LINK, V.C., WEINBERG, R.A., and GREENE, M.I. (1986). Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc. Natl. Acad. Sci. USA 83, 9129-1933.
9. EASTON, D.F., FORD, D., and BISHOP, D.T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers (Breast Cancer Linkage Consortium). Am. J. Hum. Genet. 56, 265-271.
10. EGERTON, M., ASHE, O.R., CHEN, D., DRUKER, B.J., BURGESS, W.H., and SAMELSON, L.E. (1992). VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J. 11, 3533-3540.
11. EGERTON, M., and SAMELSON, L.E. (1994). Biochemical characterization of valosin-containing protein, a protein tyrosine kinase substrate in hematopoietic cells. J. Biol. Chem. 269, 11435-11441.
12. FROHLICH, K.U., FRIES, H.W., RUDIGER, M., ERDMANN, R., BOTSTEIN, D., and MECKE, D. (1991). Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression. J. Cell Biol. 114, 443-453.
13. GOWEN, L.C., AVRUTSKAYA, A.V., LATOUR, A.M., KOLLER, B.H., and LEADON, S.A. (1998). BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009-1012.
14. GRADIA, S., ACHARYA, S., and FISHEL, R. (1997). The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch. Cell 91, 995-1005.
15. HAKEM, R., DE LA POMPA, J.L., SIRARD, C., MO, R., WOO, M., HAKEM, A., WAKEHAM, A., POTTER, J., REITMAIR, A., BILLIA, F., FIRPO, E., HUI, C.C., ROBERTS, J., ROSSANT, J., and MAK, T.W. (1996). The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
16. HSU, L., and WHITE, R.L. (1998). BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. USA 95, 12983-12988.
17. IACCARINO, I., MARRA, G., PALOMBO, F., and JIRICNY, J. (1998). hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha. EMBO J. 17, 2677-2686.
18. JENSEN, D.E., PROCTOR, M., MARQUIS, S.T., GARDNER, H.P., HA, S.I., CHODOSH, L.A., ISHOV, A.M., TOMMERUP, N., VISSING, H., SEKIDO, Y., MINNA, J., BORODOVSKY, A., SCHULTZ, D.C., WILKINSON, K.D., MAUL, G.G., BARLEV, N., BERGER, S.L., PRENDERGAST, G.C., and RAUSCHER, F. Jr. (1998). BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097-1112.
19. JENSEN, R.A., THOMPSON, M.E., JETTON, T.L., SZABO, C.I., VAN, DER, MEER, R, HELOU, B., TRONICK, S.R., PAGE, D.L., KING, M.C., and HOLT, J.T. (1996). BRCA1 is secreted and exhibits properties of a granin. Nature Genet. 12, 303-308.
20. KOLLER, K.J., and BROWNSTEIN, M.J. (1987). Use of a cDNA clone to identify a supposed precursor protein containing valosin. Nature 325, 542-545.
21. LANE, T.F., DENG, C., ELSON, A., LYU, M.S., KOZAK, C.A., and LEDER, P. (1995). Expression of BRCA1 is associated with terminal differentiation of ectoderm ally and mesodermally derived tissues in mice [published erratum appears in Genes Dev. 1996;10(3):365 Genes Dev. 9, 2712-2722.
22. LATTERICH, M., FROHLICH, K.U., and SCHEKMAN, R. (1995). Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell 82, 885-893.
23. LEADON, S.A., and AVRUTSKAYA, A.V. (1997). Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair. Cancer Res. 57, 3784-3791.
24. LI, S., KU, C.Y., FARMER, A.A., CONG, Y.S., CHEN, C.F., and LEE, W.H. (1998). Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J. Biol. Chem. 273, 6183-6189.
25. MADEO, F., SCHLAUER, J., and FROHLICH, K.U. (1997). Identification of the regions of porcine VCP preventing its function in Saccharomyces cerevisiae. Gene 204, 145-151.
26. MADEO, F., SCHLAUER, J., ZISCHKA, H., MECKE, D., and FROHLICH, K.U. (1998). Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p. Mol. Biol. Cell 9, 131-141.
27. MARQUIS, S.T., RAJAN, J.V., WYNSHAW-BORIS, A., XU, J., YIN, G.Y., ABEL, K.J., WEBER, B.L., and CHODOSH, L.A. (1995). The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nature Genet. 11, 17-26.
28. MIKI, Y., SWENSEN, J., SHATTUCK, E.D., FUTREAL, P.A., HARSHMAN, K., TAVTIGIAN, S., LIU, Q., COCHRAN, C., BENNETT, L.M., DING, W., BELL, R., ROSENTHAL, J., HUSSEY, C., TRAN, T., MCCLURE, M., FRYE, C., HATTIER, T., PHELPS, R., KATCHER, H., YAKUMO, K., GHOLAMI, Z., SHAFFER, D., STONE, S., BAYER, S., WRAY, C., BIGDEN, R., WARD, J., TONIN, P., NAROD, S., BRISTOW, P.K., NORRIS, F.H., HELVERING, L., NORRISON, P., ROSTECK, P., LAI, M., BARRETT, J.C., LEWIS, C., NEUHAUSEN, S., CANNON-ALBRIGHT, L., GOLDGAR, D., WISEMAN, R., KAMB, A., SKOLNICK, M.H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
29. NEUHAUSEN, S.L., and MARSHALL, C.J. (1994). Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54, 6069-6072.
30. PATEL, S., and LATTERICH, M. (1998). The AAA team: Related ATPases with diverse functions. Trends Cell Biol. 8, 65-71.
31. PLEASURE, I.T., BLACK, M.M., and KEEN, J.H. (1993). Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature 365, 459-462.
32. RAO, V.N., SHAO, N., AHMAD, M., and REDDY, E.S. (1996). Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12, 523-528.
33. SCULLY, R., ANDERSON, S.F., CHAO, D.M., WEI, W., YE, L., YOUNG, R.A., LIVINGSTON, D.M., and PARVIN, J.D. (1997a). BRCA1 is acomponent of the RNA polymerase IIholoenzyme. Proc. Natl. Acad. Sci. USA 94, 5605-5610.
34. SCULLY, R., CHEN, J., OCHS, R.L., KEEGAN, K., HOEKSTRA, M., FEUNTEUN, J., and LIVINGSTON, D.M. (1997b). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425-435.
35. SCULLY, R., CHEN, J., PLUG, A., XIAO, Y., WEAVER, D., FEUNTEUN, J., ASHLEY, T., and LIVINGSTON, D.M. (1997c). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275.
36. SHAO, N., CHAI, Y.L., SHYAM, E., REDDY, P., and RAO, V.N. (1996). Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13, 1-7.
37. STRUEWING, J.P., HARTGE, P., WACHOLDER, S., BAKER, S.M., BERLIN, M., MCADAMS, M., TIMMERMAN, M.M., BRODY, L.C., and TUCKER, M.A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336, 1401-1408.
38. THOMAS, J.E., SMITH, M., TONKINSON, J.L., RUBINFELD, B., and POLAKIS, P. (1997). Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ. 8, 801-809.
39. THOMPSON, M.E., JENSEN, R.A., OBERMILLER, P.S., PAGE, D.L., and HOLT, J.T. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444-450.
40. WALKER, J.E., SARASTE, M., RUNSWICK, M.J., and GAY, N.J. (1982). Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1, 945-951.
41. WANG, Q., ZHANG, H., KAJINO, K., and GREENE, M.I. (1998). BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17, 1939-1948.
42. WU, L.C., WANG, Z.W., TSAN, J.T., SPILLMAN, M.A., PHUNG, A., XU, X.L., YANG, M.C., HWANG, L.Y., BOWCOCK, A.M., and BAER, R. (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genet. 14, 430-440.
43. XU, X., WEAVER, Z., LINKE, S.P., LI, C., GOTAY, J., WANG, X.W., HARRIS, C.C., RIED, T., and DENG, C.X. (1999). Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-395.
44. ZHANG, H., SOMASUNDARAM, K., PENG, Y., TIAN, H., ZHANG, H., BI, D., WEBER, B.L., and EL-DEIRY, W.S. (1998). BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713-1721.
45. ZHANG, H.T., ZHANG, X., ZHAO, H.Z., KAJINO, Y., WEBER, B.L., DAVIS, J.G., WANG, Q., O'ROURKE, D.M., ZHANG, H.B., KAJINO, K., and GREENE, M.I. (1997). Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14, 2863-2869.
46. ZHANG, L., ASHENDEL, C.L., BECKER, G.W., and MORRE, D.J. (1994). Isolation and characterization of the principal ATPase associated with transitional endoplasmic reticulum of rat liver. J. Cell Biol. 127, 1871-1883.